Breast Cancer,TNBC (Triple Negative Breast Cancer) Patient Outcomes after Chemo Stop and with Immune-Mediated AEs before Pembrolizumab Aug 18, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Pilot Study of Micro-Organosphere Drug Screen for ABC Aug 17, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Role of FTD/TPI in HER2 Negative Metastatic Breast Cancer Aug 17, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) HER3-DXd in HR+/HER2- and TNBC: SOLTI TOT-HER3 Part B Results Aug 16, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Long-term PROs of Abemaciclib Plus ET For Adjuvant HR+, HER2-, Node-positive, High-risk, EBC Aug 16, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) ctDNA Dynamics in Pts Receiving CAPE for eTNBC With an Incomplete Response to NAT Aug 11, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) PROs in Pts With ER+/HER2- Advanced or mBC Comparing Oral Elacestrant vs SoC ET Aug 11, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Neoadjuvant Atezo + CT Followed by Open-Label Adjuvant Atezo in pts with eTNBC Jul 28, 2023
